You are viewing an incomplete version of our website. Please click to reload the website as full version.

BCL2 Binding Component 3 (BBC3) (C-Term) Peptide

Details for Product No. ABIN1382123, Supplier: Log in to see
Protein Name
  • BBC3
  • JFY-1
  • JFY1
  • Puma
  • PUMA
Protein Region
Blocking Peptide (BP)
Log in to see
Supplier Product No.
Log in to see

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Blocked Antibody anti-BBC3 antibody (BCL2 Binding Component 3) (C-Term) (ABIN1030609)
Characteristics 14 amino acids near the carboxy terminus of human PUMA.
Research Area Cancer, Apoptosis/Necrosis, Metabolism
Application Notes PUMA peptide is used for blocking the. activity of PUMA.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Stilo, Liguoro, Di Jeso et al.: "Physical and functional interaction of CARMA1 and CARMA3 with Ikappa kinase gamma-NFkappaB essential modulator." in: The Journal of biological chemistry, Vol. 279, Issue 33, pp. 34323-31, 2004 (PubMed).

Fischer, Tedford, Wirth: "New roles for Bcl10 in B-cell development and LPS response." in: Trends in immunology, Vol. 25, Issue 3, pp. 113-6, 2004 (PubMed).

Nakano, Vousden: "PUMA, a novel proapoptotic gene, is induced by p53." in: Molecular cell, Vol. 7, Issue 3, pp. 683-94, 2001 (PubMed).